Graft Solutions is a leading brand at the forefront of advancing coronary bypass surgery with state-of-the-art technologies. They address the biggest challenges in this field, including the poor longevity of vein grafts and procedure-related neurological complications. With a focus on patients' quality of life and reducing the economic burden on healthcare providers, Graft Solutions aims to improve the standard-of-care surgery.

One of their innovative products is VIOLA™, which enables clampless proximal anastomosis. Its novel design allows for optimal hemostasis and construction of multiple aortic anastomoses without the need for an aortic clamp. This helps reduce peri-operative stroke and delirium events associated with CABG procedures.

Another remarkable product offered by Graft Solutions is VEST™, which provides external support for vein grafts in CABG. Through randomized clinical trials and real-world data, it has shown significant reductions in vein graft disease and improvements in the clinical outcome of CABG. These include reducing intimal hyperplasia, lumen irregularities, and ischemic-driven revascularization.

Join Graft Solutions in their continuous journey to improve coronary surgery and enhance patients' quality of life